Literature DB >> 11681709

Insulin like growth factor-1 selectively regulates the expression of matrix metalloproteinase-2 in malignant H-ras transformed cells.

A Yoon1, R A Hurta.   

Abstract

The present study demonstrates alterations in the regulation of matrix metalloproteinase-2 (MMP-2) expression in response to insulin like growth factor-1 (IGF-1) in a H-ras transformed cell line, C3, which is capable of metastasis formation. These changes in MMP-2 expression in response to IGF-1 treatment did not occur in either non-transformed parental 10 T 1/2 cells or in H-ras transformed cells (NR3 cells) which are capable of benign tumour formation. IGF-1 treatment of C3 cells resulted in increased expression of MMP-2 gelatinolytic activity and increased expression of MMP-2 mRNA levels. The IGF-1 mediated alterations in MMP-2 mRNA levels were dependent upon de novo protein synthesis and independent of transcriptional events, but dependent upon post-transcriptional regulatory events. Most notably, IGF-1 can regulate MMP-2 mRNA expression in C3 cells through a mechanism involving MMP-2 message stabilization. This study demonstrates aspects of the temporal regulatory mechanisms of MMP-2 expression in response to insulin-like growth factor-1 in a H-ras transformed fibrosarcoma cell line capable of metastasis formation and thereby, provides further insight into the altered growth regulatory program associated with H-ras mediated cellular transformation and malignant progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11681709     DOI: 10.1023/a:1017549222677

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  17 in total

1.  Overview of matrix metalloproteinase expression in cultured human cells.

Authors:  T A Giambernardi; G M Grant; G P Taylor; R J Hay; V M Maher; J J McCormick; R J Klebe
Journal:  Matrix Biol       Date:  1998-03       Impact factor: 11.583

2.  Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.

Authors:  S E Egan; G A McClarty; L Jarolim; J A Wright; I Spiro; G Hager; A H Greenberg
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

Review 3.  Ras-responsive genes and tumor metastasis.

Authors:  A F Chambers; A B Tuck
Journal:  Crit Rev Oncog       Date:  1993

Review 4.  Genetic regulation of metastatic progression.

Authors:  J A Wright; S E Egan; A H Greenberg
Journal:  Anticancer Res       Date:  1990 Sep-Oct       Impact factor: 2.480

5.  Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1).

Authors:  M P Vincenti; C I Coon; J A Mengshol; S Yocum; P Mitchell; C E Brinckerhoff
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

6.  Regulation of human interstitial collagenase (matrix metalloproteinase-1) promoter activity by fibroblast growth factor.

Authors:  S Aho; S Rouda; S H Kennedy; H Qin; E M Tan
Journal:  Eur J Biochem       Date:  1997-07-15

7.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.

Authors:  A Nakano; E Tani; K Miyazaki; Y Yamamoto; J Furuyama
Journal:  J Neurosurg       Date:  1995-08       Impact factor: 5.115

8.  Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.

Authors:  P Huhtala; A Tuuttila; L T Chow; J Lohi; J Keski-Oja; K Tryggvason
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

9.  Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development.

Authors:  J P Witty; J H Wright; L M Matrisian
Journal:  Mol Biol Cell       Date:  1995-10       Impact factor: 4.138

Review 10.  MMP-2: expression, activation and inhibition.

Authors:  M L Corcoran; R E Hewitt; D E Kleiner; W G Stetler-Stevenson
Journal:  Enzyme Protein       Date:  1996
View more
  10 in total

1.  The anti-angiogenic peptide, loop 6, binds insulin-like growth factor-1 receptor.

Authors:  Cecilia A Fernandez; Roopali Roy; Sunyoung Lee; Jiang Yang; Dipak Panigrahy; Krystyn J Van Vliet; Marsha A Moses
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

Review 2.  Cancer.

Authors:  Adda Grimberg
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

3.  Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.

Authors:  Kathryn M Thrailkill; Cindy S Moreau; Gael Cockrell; Pippa Simpson; Rajiv Goel; Paula North; John L Fowlkes; Robert C Bunn
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

4.  Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.

Authors:  Ga Bin Park; Daejin Kim
Journal:  Mol Cell Biochem       Date:  2017-08-17       Impact factor: 3.396

Review 5.  Mechanisms by which IGF-I may promote cancer.

Authors:  Adda Grimberg
Journal:  Cancer Biol Ther       Date:  2003 Nov-Dec       Impact factor: 4.742

6.  Regulation of insulin-like growth factor receptors by Ubiquilin1.

Authors:  Zimple Kurlawala; Rain Dunaway; Parag P Shah; Julie A Gosney; Leah J Siskind; Brian P Ceresa; Levi J Beverly
Journal:  Biochem J       Date:  2017-12-06       Impact factor: 3.857

7.  Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells.

Authors:  Ya-Wen Chen; Victor Boyartchuk; Brian C Lewis
Journal:  Neoplasia       Date:  2009-09       Impact factor: 5.715

Review 8.  IGF signalling in germ cells and testicular germ cell tumours: roles and therapeutic approaches.

Authors:  J Selfe; J M Shipley
Journal:  Andrology       Date:  2019-06-09       Impact factor: 3.842

9.  Salidroside, 8(E)-Nuezhenide, and Ligustroside from Ligustrum japonicum Fructus Inhibit Expressions of MMP-2 and -9 in HT 1080 Fibrosarcoma.

Authors:  Hojun Kim; Chang-Suk Kong; Youngwan Seo
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

10.  Plasmodium infection inhibits tumor angiogenesis through effects on tumor-associated macrophages in a murine implanted hepatoma model.

Authors:  Benfan Wang; Qinyan Li; Jinyan Wang; Siting Zhao; Bayaer Nashun; Li Qin; Xiaoping Chen
Journal:  Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.712

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.